Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
MCL1 is essential for the survival of stem and progenitor cells of multiple lineages, and is unique among pro-survival BCL2 family members in that it is rapidly turned over through the action of ubiquitin ligases. B- and mantle-cell lymphomas, chronic myeloid leukaemia, and multiple myeloma, however, express abnormally high levels of MCL1, contributing to chemoresistance and disease relapse. The mechanism of MCL1 overexpression in cancer is not well understood. Here we show that the deubiquitinase USP9X stabilizes MCL1 and thereby promotes cell survival. USP9X binds MCL1 and removes the Lys 48-linked polyubiquitin chains that normally mark MCL1 for proteasomal degradation. Increased USP9X expression correlates with increased MCL1 protein in human follicular lymphomas and diffuse large B-cell lymphomas. Moreover, patients with multiple myeloma overexpressing USP9X have a poor prognosis. Knockdown of USP9X increases MCL1 polyubiquitination, which enhances MCL1 turnover and cell killing by the BH3 mimetic ABT-737. These results identify USP9X as a prognostic and therapeutic target, and they show that deubiquitinases may stabilize labile oncoproteins in human malignancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Phosphorylation of MCL1 at S159 and T163 also affects the USP9X-MCL1 interaction [121].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [121]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112
van Delft, M. F., Wei, A. H., Mason, K. D., Vandenberg, C. J., Chen, L., Czabotar, P. E., Willis, S. N., Scott, C. L., Day, C. L., Cory, S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.027 · Cited by 1,240
Self-citationThe molecular classification of multiple myeloma
Zhan, F., Huang, Y., Colla, S., Stewart, J. P., Hanamura, I., Gupta, S., Epstein, J., Yaccoby, S., Sawyer, J., Burington, B., et al. (2006) · Blood · doi:10.1182/blood-2005-11-013458 · Cited by 1,133
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
Hummel, M., Bentink, S., Berger, H., Klapper, W., Wessendorf, S., Barth, T. F. E., Bernd, H.-W., Cogliatti, S. B., Dierlamm, J., Feller, A. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055351 · Cited by 1,006
Maurer, U., Charvet, C., Wagman, A. S., Dejardin, E., & Green, D. R. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.009 · Cited by 881
Zhong, Q., Gao, W., Du, F., & Wang, X. (2005) · Cell · doi:10.1016/j.cell.2005.06.009 · Cited by 842
Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1
Opferman, J. T., Letai, A., Beard, C., Sorcinelli, M. D., Ong, C. C., & Korsmeyer, S. J. (2003) · Nature · doi:10.1038/nature02067 · Cited by 801
Cited by
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
Czabotar, P. E., Lessene, G., Strasser, A., & Adams, J. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3722 · Cited by 3,219
Chipuk, J. E., Moldoveanu, T., Llambi, F., Parsons, M. J., & Green, D. R. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.025 · Cited by 1,427
Green, D. R., & Llambi, F. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a006080 · Cited by 1,101
The increasing complexity of the ubiquitin code
Yau, R., & Rape, M. (2016) · Nature Cell Biology · doi:10.1038/ncb3358 · Cited by 1,054
Breaking the chains: deubiquitylating enzyme specificity begets function
Clague, M. J., Urbé, S., & Komander, D. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0099-1 · Cited by 832
Mechanisms of Action of Bcl-2 Family Proteins
Shamas-Din, A., Kale, J., Leber, B., & Andrews, D. W. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008714 · Cited by 705
SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
Inuzuka, H., Shaik, S., Onoyama, I., Gao, D., Tseng, A., Maser, R. S., Zhai, B., Wan, L., Gutierrez, A., Lau, A. W., et al. (2011) · Nature · doi:10.1038/nature09732 · Cited by 632
Fernald, K., & Kurokawa, M. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.07.006 · Cited by 579
Cancer stem cells: advances in knowledge and implications for cancer therapy
Chu, X., Tian, W., Ning, J., Xiao, G., Zhou, Y., Wang, Z., Zhai, Z., Tanzhu, G., Yang, J., & Zhou, R. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01851-y · Cited by 553
New roles for mitochondrial proteases in health, ageing and disease
Quirós, P. M., Langer, T., & López-Otín, C. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3984 · Cited by 546
Mcl‐1; the molecular regulation of protein function
Thomas, L. W., Lam, C., & Edwards, S. W. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.05.061 · Cited by 538
Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases
Strasser, A., Cory, S., & Adams, J. M. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.307 · Cited by 532
BCL-2 protein family: attractive targets for cancer therapy
Kaloni, D., Diepstraten, S. T., Strasser, A., & Kelly, G. L. (2023) · Apoptosis · doi:10.1007/s10495-022-01780-7 · Cited by 500
Deubiquitinases in cancer: new functions and therapeutic options
Fraile, J. M., Quesada, V, Rodríguez, D., Freije, J. M. P., & López-Otín, C. (2012) · Oncogene · doi:10.1038/onc.2011.443 · Cited by 453
Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death
Vucic, D., Dixit, V. M., & Wertz, I. E. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3143 · Cited by 444
Self-citationDrugging the undruggables: exploring the ubiquitin system for drug development
Huang, X., & Dixit, V. M. (2016) · Cell Research · doi:10.1038/cr.2016.31 · Cited by 427
Self-citationAnti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia
Glaser, S. P., Lee, E. F., Trounson, E., Bouillet, P., Wei, A., Fairlie, W. D., Izon, D. J., Zuber, J., Rappaport, A. R., Herold, M. J., et al. (2012) · Genes & Development · doi:10.1101/gad.182980.111 · Cited by 423
Perciavalle, R. M., Stewart, D. P., Koss, B., Lynch, J., Milasta, S., Bathina, M., Temirov, J., Cleland, M. M., Pelletier, S., Schuetz, J. D., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2488 · Cited by 410
Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes
Altun, M., Kramer, H. B., Willems, L. I., McDermott, J. L., Leach, C. A., Goldenberg, S. J., Kumar, K. G. S., Konietzny, R., Fischer, R., Kogan, E., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.08.018 · Cited by 402
Li, L., Shi, L., Yang, S., Yan, R., Zhang, D., Yang, J., He, L., Li, W., Yi, X., Sun, L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12235 · Cited by 391
Kapuria, V., Peterson, L. F., Fang, D., Bornmann, W. G., Talpaz, M., & Donato, N. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1530 · Cited by 383
Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities
Schmidt, M. F., Gan, Z. Y., Komander, D., & Dewson, G. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00706-7 · Cited by 368
BH3-only proteins: Orchestrators of apoptosis
Shamas-Din, A., Brahmbhatt, H., Leber, B., & Andrews, D. W. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.11.024 · Cited by 369
Harley, M. E., Allan, L. A., Sanderson, H. S., & Clarke, P. R. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.112 · Cited by 353
Dewson, G., Eichhorn, P. J. A., & Komander, D. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00633-y · Cited by 326
Insights into new mechanisms and models of cancer stem cell multidrug resistance
Garcia-Mayea, Y., Mir, C., Masson, F., Paciucci, R., & LLeonart, M. E. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.022 · Cited by 324
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma
Initiative, A. P. C. G., Pérez-Mancera, P. A., Rust, A. G., van der Weyden, L., Kristiansen, G., Li, A., Sarver, A. L., Silverstein, K. A. T., Grützmann, R., Aust, D., et al. (2012) · Nature · doi:10.1038/nature11114 · Cited by 316
Deubiquitinase inhibition as a cancer therapeutic strategy
D'Arcy, P., Wang, X., & Linder, S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.002 · Cited by 310
Targeting MCL-1 in cancer: current status and perspectives
Wang, H., Guo, M., Wei, H., & Chen, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01079-1 · Cited by 301
Targeting the Bcl-2 family for cancer therapy
Thomas, S., Quinn, B. A., Das, S. K., Dash, R., Emdad, L., Dasgupta, S., Wang, X.-Y., Dent, P., Reed, J. C., Pellecchia, M., et al. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.733001 · Cited by 277
Apoptosis and oncogenesis: give and take in the BCL-2 family
Llambi, F., & Green, D. R. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.12.001 · Cited by 262
Regulating mitochondrial outer membrane proteins by ubiquitination and proteasomal degradation
Karbowski, M., & Youle, R. J. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.05.007 · Cited by 258
Zismanov, V., Chichkov, V., Colangelo, V., Jamet, S., Wang, S., Syme, A., Koromilas, A. E., & Crist, C. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2015.09.020 · Cited by 248
Niu, X., Zhao, J., Ma, J., Xie, C., Edwards, H., Wang, G., Caldwell, J. T., Xiang, S., Zhang, X., Chu, R., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-3057 · Cited by 248
The AAA-ATPase p97 is essential for outer mitochondrial membrane protein turnover
Xu, S., Peng, G., Wang, Y., Fang, S., & Karbowski, M. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-09-0748 · Cited by 243
Organelle-specific initiation of cell death
Galluzzi, L., Bravo-San Pedro, J. M., & Kroemer, G. (2014) · Nature Cell Biology · doi:10.1038/ncb3005 · Cited by 239
Mennerich, D., Kubaichuk, K., & Kietzmann, T. (2019) · Trends in Cancer · doi:10.1016/j.trecan.2019.08.005 · Cited by 235
Delving deeper: MCL-1's contributions to normal and cancer biology
Perciavalle, R. M., & Opferman, J. T. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.08.011 · Cited by 230
The role of Ubiquitination in Apoptosis and Necroptosis
Roberts, J. Z., Crawford, N., & Longley, D. B. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-021-00922-9 · Cited by 229
Decoding and unlocking the BCL-2 dependency of cancer cells
Juin, P., Geneste, O., Gautier, F., Depil, S., & Campone, M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3538 · Cited by 232
Regulation of Bim in Health and Disease
Sionov, R. V., Vlahopoulos, S. A., & Granot, Z. (2015) · Oncotarget · doi:10.18632/oncotarget.5492 · Cited by 216
Bcl-2 Antiapoptotic Family Proteins and Chemoresistance in Cancer
(2018) · Advances in Cancer Research · doi:10.1016/bs.acr.2017.11.001 · Cited by 215
Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma
Mann, K. M., Ward, J. M., Yew, C. C. K., Kovochich, A., Dawson, D. W., Black, M. A., Brett, B. T., Sheetz, T. E., Dupuy, A. J., Initiative, A. P. C. G., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202490109 · Cited by 213
Targeting MCL-1 in hematologic malignancies: Rationale and progress
Wei, A. H., Roberts, A. W., Spencer, A., Rosenberg, A. S., Siegel, D., Walter, R. B., Caenepeel, S., Hughes, P., McIver, Z., Mezzi, K., et al. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100672 · Cited by 210
Targeting Mcl-1 for the therapy of cancer
Quinn, B. A., Dash, R., Azab, B., Sarkar, S., Das, S. K., Kumar, S., Oyesanya, R. A., Dasgupta, S., Dent, P., Grant, S., et al. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.609167 · Cited by 202
Pal, A., Young, M. A., & Donato, N. J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1211 · Cited by 199
Proteasome Inhibitors for the Treatment of Multiple Myeloma
Ito, S. (2020) · Cancers · doi:10.3390/cancers12020265 · Cited by 197
Jia, J., Bissa, B., Brecht, L., Allers, L., Choi, S. W., Gu, Y., Zbinden, M., Burge, M. R., Timmins, G., Hallows, K., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2019.12.028 · Cited by 191
La FAM fatale: USP9X in development and disease
Murtaza, M., Jolly, L. A., Gecz, J., & Wood, S. A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1851-0 · Cited by 184
Mcl-1 Ubiquitination: Unique Regulation of an Essential Survival Protein
Mojsa, B., Lassot, I., & Desagher, S. (2014) · Cells · doi:10.3390/cells3020418 · Cited by 181
Genetically engineered mouse models of pancreatic adenocarcinoma
Guerra, C., & Barbacid, M. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.02.002 · Cited by 179
MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma
Jin, L., Hu, W. L., Jiang, C. C., Wang, J. X., Han, C. C., Chu, P., Zhang, L. J., Thorne, R. F., Wilmott, J., Scolyer, R. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019312108 · Cited by 176
The importance of regulatory ubiquitination in cancer and metastasis
Gallo, L. H., Ko, J., & Donoghue, D. J. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1288326 · Cited by 175
USP 30 deubiquitylates mitochondrial Parkin substrates and restricts apoptotic cell death
Liang, J., Martinez, A., Lane, J. D., Mayor, U., Clague, M. J., & Urbé, S. (2015) · EMBO reports · doi:10.15252/embr.201439820 · Cited by 169
Deubiquitinases Maintain Protein Homeostasis and Survival of Cancer Cells upon Glutathione Depletion
Harris, I. S., Endress, J. E., Coloff, J. L., Selfors, L. M., McBrayer, S. K., Rosenbluth, J. M., Takahashi, N., Dhakal, S., Koduri, V., Oser, M. G., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.020 · Cited by 170
MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
Bolomsky, A., Vogler, M., Köse, M. C., Heckman, C. A., Ehx, G., Ludwig, H., & Caers, J. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-01007-9 · Cited by 168
Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment
Correia, C., Lee, S.-H., Meng, X. W., Vincelette, N. D., Knorr, K. L. B., Ding, H., Nowakowski, G. S., Dai, H., & Kaufmann, S. H. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.03.012 · Cited by 166
The role of ubiquitin-specific peptidases in cancer progression
Young, M.-J., Hsu, K.-C., Lin, T. E., Chang, W.-C., & Hung, J.-J. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0522-0 · Cited by 164
Tong, J., Tan, S., Zou, F., Yu, J., & Zhang, L. (2017) · Oncogene · doi:10.1038/onc.2016.247 · Cited by 159
Targeting the Bcl-2 Family in B Cell Lymphoma
Adams, C. M., Clark-Garvey, S., Porcu, P., & Eischen, C. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00636 · Cited by 159
Deubiquitinase USP37 Is Activated by CDK2 to Antagonize APCCDH1 and Promote S Phase Entry
Huang, X., Summers, M. K., Pham, V. C., Lill, J. R., Liu, J., Lee, G., Kirkpatrick, D. S., Jackson, P. K., Fang, G., & Dixit, V. M. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.03.027 · Cited by 175
Self-citationJNK-mediated phosphorylation of DLK suppresses its ubiquitination to promote neuronal apoptosis
Huntwork-Rodriguez, S., Wang, B., Watkins, T., Ghosh, A. S., Pozniak, C. D., Bustos, D., Newton, K., Kirkpatrick, D. S., & Lewcock, J. W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201303066 · Cited by 154
Tumor suppressor functions of FBW7 in cancer development and progression
Wang, Z., Inuzuka, H., Zhong, J., Wan, L., Fukushima, H., Sarkar, F. H., & Wei, W. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.03.017 · Cited by 154
Saga of Mcl-1: regulation from transcription to degradation
Senichkin, V. V., Streletskaia, A. Y., Gorbunova, A. S., Zhivotovsky, B., & Kopeina, G. S. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0486-3 · Cited by 155
Hikita, H., Takehara, T., Shimizu, S., Kodama, T., Shigekawa, M., Iwase, K., Hosui, A., Miyagi, T., Tatsumi, T., Ishida, H., et al. (2010) · Hepatology · doi:10.1002/hep.23836 · Cited by 150
Homan, C. C., Kumar, R., Nguyen, L. S., Haan, E., Raymond, F. L., Abidi, F., Raynaud, M., Schwartz, C. E., Wood, S. A., Gécz, J., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.02.004 · Cited by 169
Cotargeting BCL-2 and PI3K Induces BAX-Dependent Mitochondrial Apoptosis in AML Cells
Rahmani, M., Nkwocha, J., Hawkins, E., Pei, X., Parker, R. E., Kmieciak, M., Leverson, J. D., Sampath, D., Ferreira-Gonzalez, A., & Grant, S. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3024 · Cited by 145
USP8 Is a Novel Target for Overcoming Gefitinib Resistance in Lung Cancer
Byun, S., Lee, S.-Y., Lee, J., Jeong, C.-H., Farrand, L., Lim, S., Reddy, K., Kim, J. Y., Lee, M.-H., Lee, H. J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3696 · Cited by 147
Xu, S., Cherok, E., Das, S., Li, S., Roelofs, B. A., Ge, S. X., Polster, B. M., Boyman, L., Lederer, W. J., Wang, C., et al. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-09-0678 · Cited by 146
Resistance to Cell Death and Its Modulation in Cancer Stem Cells
Safa, A. R. (2016) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2016016976 · Cited by 152
Mcl-1 Degradation Is Required for Targeted Therapeutics to Eradicate Colon Cancer Cells
Tong, J., Wang, P., Tan, S., Chen, D., Nikolovska-Coleska, Z., Zou, F., Yu, J., & Zhang, L. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3242 · Cited by 129
Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors
Zhang, S., Zhang, M., Jing, Y., Yin, X., Ma, P., Zhang, Z., Wang, X., Di, W., & Zhuang, G. (2018) · Nature Communications · doi:10.1038/s41467-017-02693-9 · Cited by 144
Inhibition of Ubiquitin-Specific Proteases as a Novel Anticancer Therapeutic Strategy
Yuan, T., Yan, F., Ying, M., Cao, J., He, Q., Zhu, H., & Yang, B. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01080 · Cited by 155
Bouska, A. C., McKeithan, T. W., Deffenbacher, K. E., Lachel, C. M., Wright, G. W., Iqbal, J., Smith, L. M., Zhang, W., Küçük, C., Rinaldi, A., et al. (2013) · Blood · doi:10.1182/blood-2013-05-500595 · Cited by 139
Coloff, J. L., Macintyre, A. N., Nichols, A., Liu, T., Gallo, C. A., Plas, D. R., & Rathmell, J. C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4531 · Cited by 151
Briston, T., & Hicks, A. R. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180025 · Cited by 131
Spindle Poisons and Cell Fate: A Tale of Two Pathways
Matson, D. R., & Stukenberg, P. T. (2011) · Molecular Interventions · doi:10.1124/mi.11.2.12 · Cited by 148
Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer
Wang, S., Kollipara, R. K., Srivastava, N., Li, R., Ravindranathan, P., Hernández, E., Freeman, E., Humphries, C. G., Kapur, P., Lotan, Y., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322198111 · Cited by 136
BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy
Ramesh, P., & Medema, J. P. (2020) · Apoptosis · doi:10.1007/s10495-020-01601-9 · Cited by 127
Zheng, X., Zhai, B., Koivunen, P., Shin, S. J., Lu, G., Liu, J., Geisen, C., Chakraborty, A. A., Moslehi, J. J., Smalley, D. M., et al. (2014) · Genes & Development · doi:10.1101/gad.242131.114 · Cited by 128
Self-citationPeterson, L. F., Sun, H., Liu, Y., Potu, H., Kandarpa, M., Ermann, M., Courtney, S. M., Young, M., Showalter, H. D., Sun, D., et al. (2015) · Blood · doi:10.1182/blood-2014-10-605584 · Cited by 124
Ubiquitin-Independent Degradation of Antiapoptotic MCL-1
Stewart, D. P., Koss, B. S., Bathina, M., Perciavalle, R. M., Bisanz, K. M., & Opferman, J. T. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01266-09 · Cited by 130
USP9X regulates centrosome duplication and promotes breast carcinogenesis
Li, X., Song, N., Liu, L., Liu, X., Ding, X. D., Song, X., Yang, S., Shan, L., Zhou, X., Su, D., et al. (2017) · Nature Communications · doi:10.1038/ncomms14866 · Cited by 124
The ubiquitin system: a critical regulator of innate immunity and pathogen–host interactions
Li, J., Chai, Q., & Liu, C. H. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.40 · Cited by 126
Shi, D., & Grossman, S. R. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.8.13417 · Cited by 132
Mazumder, S., Choudhary, G. S., Al-harbi, S., & Almasan, A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4106 · Cited by 126
Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL
Karpel-Massler, G., Ishida, C. T., Bianchetti, E., Zhang, Y., Shu, C., Tsujiuchi, T., Banu, M. A., Garcia, F., Roth, K. A., Bruce, J. N., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00984-9 · Cited by 116
POH1 deubiquitylates and stabilizes E2F1 to promote tumour formation
Wang, B., Ma, A., Zhang, L., Jin, W., Qian, Y., Xu, G., Qiu, B., Yang, Z., Liu, Y., Xia, Q., et al. (2015) · Nature Communications · doi:10.1038/ncomms9704 · Cited by 123
Emerging regulatory mechanisms in ubiquitin-dependent cell cycle control
Mocciaro, A., & Rapé, M. (2012) · Journal of Cell Science · doi:10.1242/jcs.091199 · Cited by 122
The ubiquitous nature of cancer: the role of the SCFFbw7 complex in development and transformation
Crusio, K. M., King, B., Reavie, L. B., & Aifantis, I. (2010) · Oncogene · doi:10.1038/onc.2010.222 · Cited by 113
The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer
Khan, O. M., Carvalho, J., Spencer‐Dene, B., Mitter, R., Frith, D., Snijders, A. P., Wood, S. A., & Behrens, A. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97325 · Cited by 121
Unraveling the journey of cancer stem cells from origin to metastasis
Nimmakayala, R. K., Batra, S. K., & Ponnusamy, M. P. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.10.006 · Cited by 123
Bcr-Abl ubiquitination and Usp9x inhibition block kinase signaling and promote CML cell apoptosis
Sun, H., Kapuria, V., Peterson, L. F., Fang, D., Bornmann, W. G., Bartholomeusz, G., Talpaz, M., & Donato, N. J. (2011) · Blood · doi:10.1182/blood-2010-03-276477 · Cited by 112
Xie, Y., Avello, M., Schirle, M., McWhinnie, E. A., Feng, Y., Bric-Furlong, E., Wilson, C. J., Nathans, R. S., Zhang, J., Kirschner, M. W., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.430066 · Cited by 117
K63-Linked Ubiquitination in Kinase Activation and Cancer
Wang, G., Gao, Y., Li, L., Jin, G., Cai, Z., Chao, J. I., & Lin, H.-K. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00005 · Cited by 124
Li, X., Stevens, P. D., Yang, H., Gulhati, P., Wang, W., Evers, B. M., & Gao, T. (2012) · Oncogene · doi:10.1038/onc.2012.66 · Cited by 114
Reijnders, M. R. F., Zachariadis, V., Latour, B. L., Jolly, L. A., Mancini, G. M. S., Pfundt, R., Wu, K. M., van Ravenswaaij‐Arts, C. M. A., Veenstra‐Knol, H. E., Anderlid, B., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.12.015 · Cited by 122
Deubiquitylating Enzymes in Cancer and Immunity
Ren, J., Yu, P., Liu, S., Li, R., Niu, X., Chen, Y., Zhang, Z., Zhou, F., & Zhang, L. (2023) · Advanced Science · doi:10.1002/advs.202303807 · Cited by 133
Trim17-mediated ubiquitination and degradation of Mcl-1 initiate apoptosis in neurons
Magiera, M. M., Mora, S., Mojsa, B., Robbins, I. J., Lassot, I., & Desagher, S. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.124 · Cited by 131
Metadata
- Authors
- Schwickart, M., Huang, X., Lill, J. R., Liu, J., Ferrando, R., French, D. M., Maecker, H., O’Rourke, K., Bazan, F., Eastham-Anderson, J., Yue, P., Dornan, D., Huang, D. C. S., & Dixit, V. M.
- Affiliations
- Genentech (US)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Corresponding author
- Dixit, Vishva M.
- Venue
- Nature
- Published
- 2009-12-20
- Volume
- 463
- Issue
- 7277
- Pages
- 103-107
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1991249033
- Cited by
- 628
- References
- 31
- Citations by year
- 2026: 18 · 2025: 21 · 2024: 20 · 2023: 21 · 2022: 20 · 2021: 38 · 2020: 41 · 2019: 44 · 2018: 45 · 2017: 45 · 2016: 51 · 2015: 49 · 2014: 50 · 2013: 46 · 2012: 44
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- USP9X, Mcl-1, deubiquitinase, protein stabilization, ubiquitination, multiple myeloma, Bcl-2 family proteins, apoptosis, ABT-737, BH3 mimetics, follicular lymphoma, diffuse large B-cell lymphoma, chemoresistance, therapeutic target, prognosis, proteasomal degradation, stem/progenitor cells, tumor cell survival
- MeSH terms
- Docetaxel, Animals, Biphenyl Compounds, Cell Line, Cell Survival, DNA Damage, Etoposide, Female, Half-Life, Humans, Lysine, Neoplasms, Nitrophenols, Phosphorylation, Piperazines, Prognosis, Protein Binding, Sulfonamides, Ultraviolet Rays, Gene Expression Regulation, Neoplastic, Mice, SCID, Apoptosis, Proto-Oncogene Proteins c-bcl-2, Xenograft Model Antitumor Assays, Polyubiquitin, RNA Interference, Ubiquitin Thiolesterase, Taxoids, Cell Line, Tumor, Mice, Ubiquitination, Protein Stability, Gene Knockdown Techniques, Myeloid Cell Leukemia Sequence 1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.